Excludes most of Asia: Tacrolimus licensing deal links Sucampo, Fujisawa

April 15, 2002

Bethesda, MD-Sucampo Pharmaceuticals Inc. has won the exclusive right to license Fujisawa's tacrolimus for ophthalmic use in the United States, Europe, and much of the world.